Procedures for establishing and maintaining consistent air-kerma strength standards for low-energy, photon-emitting brachytherapy sources: Recommendations of the Calibration Laboratory Accreditation Subcommittee of the American Association of Physicists in Medicine

被引:31
作者
DeWerd, LA
Huq, MS
Das, IJ
Ibbott, GS
Hanson, WF
Slowey, TW
Williamson, JF
Coursey, BM
机构
[1] Univ Wisconsin, Dept Med Phys, Accredited Dosimetry Calibrat Lab, Madison, WI 53706 USA
[2] Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19107 USA
[3] Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA
[4] Univ Texas, MD Anderson Canc Ctr, Dept Radiat Phys, Accredited Dosimetry Calibrat Lab, Houston, TX 77030 USA
[5] K&S Associates, Accredited Dosimetry Calibrat Lab, Nashville, TN 37210 USA
[6] Virginia Commonwealth Univ, Dept Radiat Oncol, Richmond, VA 23298 USA
[7] Natl Inst Stand & Technol, Ionizing Radiat Div, Gaithersburg, MD 20899 USA
关键词
brachytherapy; dosimetry; low dose rate sources;
D O I
10.1118/1.1645681
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Low dose rate brachytherapy is being used extensively for the treatment of prostate cancer. As of September 2003, there are a total of thirteen I-125 and seven Pd-103 sources that have calibrations from the National Institute of Standards and Technology (NIST) and the Accredited Dosimetry Calibration Laboratories (ADCLs) of the American Association of Physicists in Medicine (AAPM). The dosimetry standards for these sources are traceable to the NIST wide-angle free-air chamber. Procedures have been developed by the AAPM Calibration Laboratory Accreditation Subcommittee to standardize quality assurance and calibration, and to maintain the dosimetric traceability of these sources to ensure accurate clinical dosimetry. A description of these procedures is provided to the clinical users for traceability purposes as well as to provide guidance to the manufacturers of brachytherapy sources and ADCLs with regard to these procedures. (C) 2004 American Association of Physicists in Medicine.
引用
收藏
页码:675 / 681
页数:7
相关论文
共 15 条
[1]   Brachytherapy for carcinoma of the prostate: Techniques, patient selection, and clinical outcomes [J].
Blasko, JC ;
Mate, T ;
Sylvester, JE ;
Grimm, PD ;
Cavanagh, W .
SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) :81-94
[2]   Palladium-103 brachytherapy for prostate carcinoma [J].
Blasko, JC ;
Grimm, PD ;
Sylvester, JE ;
Badiozamani, KR ;
Hoak, D ;
Cavanagh, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (04) :839-850
[3]  
D'Amico AV, 1999, CANCER, V86, P1632, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1632::AID-CNCR2>3.0.CO
[4]  
2-5
[5]  
DEWERD LA, 1997, CATEGORICAL COURSE B, P143
[6]   10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapy [J].
Grimm, PD ;
Blasko, JC ;
Sylvester, JE ;
Meier, RM ;
Cavanagh, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (01) :31-40
[7]   COMPREHENSIVE QA FOR RADIATION ONCOLOGY - REPORT OF AAPM RADIATION-THERAPY COMMITTEE TASK-GROUP-40 [J].
KUTCHER, GJ ;
COIA, L ;
GILLIN, M ;
HANSON, WF ;
LEIBEL, S ;
MORTON, RJ ;
PALTA, JR ;
PURDY, JA ;
REINSTEIN, LE ;
SVENSSON, GK ;
WELLER, M ;
WINGFIELD, L .
MEDICAL PHYSICS, 1994, 21 (04) :581-618
[8]   Code of practice for brachytherapy physics: Report of the AAPM Radiation Therapy Committee Task Group No. 56 [J].
Nath, R ;
Anderson, LL ;
Meli, JA ;
Olch, AJ ;
Stitt, JA ;
Williamson, JF .
MEDICAL PHYSICS, 1997, 24 (10) :1557-1598
[9]   DOSIMETRY OF INTERSTITIAL BRACHYTHERAPY SOURCES - RECOMMENDATIONS OF THE AAPM RADIATION-THERAPY COMMITTEE TASK GROUP NO 43 [J].
NATH, R ;
ANDERSON, LL ;
LUXTON, G ;
WEAVER, KA ;
WILLIAMSON, JF ;
MEIGOONI, AS .
MEDICAL PHYSICS, 1995, 22 (02) :209-234
[10]   Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations [J].
Rivard, MJ ;
Coursey, BM ;
DeWerd, LA ;
Hanson, WF ;
Huq, MS ;
Ibbott, GS ;
Mitch, MG ;
Nath, R ;
Williamson, JF .
MEDICAL PHYSICS, 2004, 31 (03) :633-674